Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial
- PMID: 16504592
- DOI: 10.1016/j.yebeh.2006.01.015
Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial
Erratum in
- Epilepsy Behav. 2006 Nov;9(3):542
Abstract
Objective: The purpose of this study was to evaluate the effectiveness and safety of methylphenidate treatment in epilepsy patients with comorbid adult attention deficit hyperactivity disorder (ADHD).
Methods: Six of 156 consecutive patients attending a tertiary epilepsy clinic for diagnostic evaluation of new seizures, 3 patients with epilepsy and 3 patients with psychogenic non-epileptic seizures, were diagnosed with comorbid adult ADHD. These 6 patients entered an open trial of methylphenidate 10 mg twice daily. Clinical improvement was assessed at 6 weeks of follow-up.
Results: Both groups showed clinical improvement of ADHD symptoms during treatment. None of the patients with comorbid epilepsy experienced adverse effects on seizure control or antiepileptic drug use.
Conclusion: In this open trial methylphenidate was safely used in patients with epilepsy and adult ADHD. It was effective against adult ADHD, and there were no adverse effects on seizure severity and frequency. A randomized study is needed to further establish effectiveness and safety.
Similar articles
-
Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.Epilepsy Behav. 2008 Feb;12(2):217-33. doi: 10.1016/j.yebeh.2007.08.001. Epub 2007 Dec 11. Epilepsy Behav. 2008. PMID: 18065271 Review.
-
Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.Curr Med Res Opin. 2006 Dec;22(12):2557-66. doi: 10.1185/030079906X154132. Curr Med Res Opin. 2006. PMID: 17166338 Clinical Trial.
-
The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.Dev Med Child Neurol. 2013 Jul;55(7):654-60. doi: 10.1111/dmcn.12121. Epub 2013 Mar 9. Dev Med Child Neurol. 2013. PMID: 23480530 Clinical Trial.
-
Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review.Epilepsy Behav. 2011 Jul;21(3):228-32. doi: 10.1016/j.yebeh.2011.02.029. Epub 2011 Apr 27. Epilepsy Behav. 2011. PMID: 21524941 Review.
-
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.J Clin Psychopharmacol. 2009 Jun;29(3):239-47. doi: 10.1097/JCP.0b013e3181a390ce. J Clin Psychopharmacol. 2009. PMID: 19440077 Clinical Trial.
Cited by
-
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants.Eur Child Adolesc Psychiatry. 2010 Apr;19(4):325-40. doi: 10.1007/s00787-009-0056-1. Epub 2009 Oct 13. Eur Child Adolesc Psychiatry. 2010. PMID: 19823900 Free PMC article. Review.
-
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.J Atten Disord. 2018 Feb;22(3):203-228. doi: 10.1177/1087054716669589. Epub 2016 Sep 1. J Atten Disord. 2018. PMID: 27664125 Free PMC article.
-
Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges.Int J Mol Sci. 2023 Mar 9;24(6):5270. doi: 10.3390/ijms24065270. Int J Mol Sci. 2023. PMID: 36982345 Free PMC article. Review.
-
Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.Epilepsy Behav. 2021 Feb;115:107627. doi: 10.1016/j.yebeh.2020.107627. Epub 2020 Dec 24. Epilepsy Behav. 2021. PMID: 33360744 Free PMC article. Review.
-
The diagnosis and treatment of attention deficit hyperactivity disorder in patients with epilepsy.Curr Neurol Neurosci Rep. 2013 Jun;13(6):351. doi: 10.1007/s11910-013-0351-6. Curr Neurol Neurosci Rep. 2013. PMID: 23636930 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
